Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant

Jason D. Huber, Vincent S. Hau, Karen S. Mark, Rachel C. Brown, Chris R. Campos, Thomas P Davis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We investigated three inflammatory agents to establish if these substances elicit a direct effect on the functional and structural integrity of the blood-brain barrier. Cellular cytotoxicity and paracellular permeability were assessed in vitro using primary bovine brain microvascular endothelial cells exposed to formalin, λ-carrageenan, or complete Freund's adjuvant for 1, 3, or 72 h, respectively. Results showed that only the highest concentration (0.025%) of formalin produced a decrease in cell viability (∼34%) and a significant increase in cell permeability to [14C]sucrose at 120 min (∼137%). Brain perfusion using female Sprague-Dawley rats showed no difference in paracellular permeability to [14C]sucrose for any inflammatory agent. Western blot analyses were performed on isolated rat brain microvessels to assess the structural integrity of blood-brain barrier tight junctions. Results indicate that expression of zonula occludens-1, occludin, claudin-1, and actin remain unchanged following intravenous exposure to inflammatory agents. This study confirms that changes seen at the blood-brain barrier following a peripheral inflammation are due to physiological responses to the given inflammatory agent and not to any direct interaction between the inflammatory agent and the brain microvasculature.

Original languageEnglish (US)
Pages (from-to)297-304
Number of pages8
JournalEuropean Journal of Pharmacology
Volume450
Issue number3
DOIs
StatePublished - Aug 30 2002

Fingerprint

Freund's Adjuvant
Carrageenan
Formaldehyde
Endothelial Cells
Blood-Brain Barrier
Permeability
Tight Junctions
Brain
Microvessels
Sucrose
Claudin-1
Occludin
Sprague Dawley Rats
Actins
Cell Survival
Perfusion
Western Blotting
Inflammation

Keywords

  • Blood-brain barrier
  • Inflammation
  • Occludin
  • Pain
  • Tight junctions
  • Zonula occludens-1

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant. / Huber, Jason D.; Hau, Vincent S.; Mark, Karen S.; Brown, Rachel C.; Campos, Chris R.; Davis, Thomas P.

In: European Journal of Pharmacology, Vol. 450, No. 3, 30.08.2002, p. 297-304.

Research output: Contribution to journalArticle

Huber, Jason D. ; Hau, Vincent S. ; Mark, Karen S. ; Brown, Rachel C. ; Campos, Chris R. ; Davis, Thomas P. / Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant. In: European Journal of Pharmacology. 2002 ; Vol. 450, No. 3. pp. 297-304.
@article{29ad54642688482a8167ab8fa40c3913,
title = "Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant",
abstract = "We investigated three inflammatory agents to establish if these substances elicit a direct effect on the functional and structural integrity of the blood-brain barrier. Cellular cytotoxicity and paracellular permeability were assessed in vitro using primary bovine brain microvascular endothelial cells exposed to formalin, λ-carrageenan, or complete Freund's adjuvant for 1, 3, or 72 h, respectively. Results showed that only the highest concentration (0.025{\%}) of formalin produced a decrease in cell viability (∼34{\%}) and a significant increase in cell permeability to [14C]sucrose at 120 min (∼137{\%}). Brain perfusion using female Sprague-Dawley rats showed no difference in paracellular permeability to [14C]sucrose for any inflammatory agent. Western blot analyses were performed on isolated rat brain microvessels to assess the structural integrity of blood-brain barrier tight junctions. Results indicate that expression of zonula occludens-1, occludin, claudin-1, and actin remain unchanged following intravenous exposure to inflammatory agents. This study confirms that changes seen at the blood-brain barrier following a peripheral inflammation are due to physiological responses to the given inflammatory agent and not to any direct interaction between the inflammatory agent and the brain microvasculature.",
keywords = "Blood-brain barrier, Inflammation, Occludin, Pain, Tight junctions, Zonula occludens-1",
author = "Huber, {Jason D.} and Hau, {Vincent S.} and Mark, {Karen S.} and Brown, {Rachel C.} and Campos, {Chris R.} and Davis, {Thomas P}",
year = "2002",
month = "8",
day = "30",
doi = "10.1016/S0014-2999(02)02150-7",
language = "English (US)",
volume = "450",
pages = "297--304",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Viability of microvascular endothelial cells to direct exposure of formalin, λ-carrageenan, and complete Freund's adjuvant

AU - Huber, Jason D.

AU - Hau, Vincent S.

AU - Mark, Karen S.

AU - Brown, Rachel C.

AU - Campos, Chris R.

AU - Davis, Thomas P

PY - 2002/8/30

Y1 - 2002/8/30

N2 - We investigated three inflammatory agents to establish if these substances elicit a direct effect on the functional and structural integrity of the blood-brain barrier. Cellular cytotoxicity and paracellular permeability were assessed in vitro using primary bovine brain microvascular endothelial cells exposed to formalin, λ-carrageenan, or complete Freund's adjuvant for 1, 3, or 72 h, respectively. Results showed that only the highest concentration (0.025%) of formalin produced a decrease in cell viability (∼34%) and a significant increase in cell permeability to [14C]sucrose at 120 min (∼137%). Brain perfusion using female Sprague-Dawley rats showed no difference in paracellular permeability to [14C]sucrose for any inflammatory agent. Western blot analyses were performed on isolated rat brain microvessels to assess the structural integrity of blood-brain barrier tight junctions. Results indicate that expression of zonula occludens-1, occludin, claudin-1, and actin remain unchanged following intravenous exposure to inflammatory agents. This study confirms that changes seen at the blood-brain barrier following a peripheral inflammation are due to physiological responses to the given inflammatory agent and not to any direct interaction between the inflammatory agent and the brain microvasculature.

AB - We investigated three inflammatory agents to establish if these substances elicit a direct effect on the functional and structural integrity of the blood-brain barrier. Cellular cytotoxicity and paracellular permeability were assessed in vitro using primary bovine brain microvascular endothelial cells exposed to formalin, λ-carrageenan, or complete Freund's adjuvant for 1, 3, or 72 h, respectively. Results showed that only the highest concentration (0.025%) of formalin produced a decrease in cell viability (∼34%) and a significant increase in cell permeability to [14C]sucrose at 120 min (∼137%). Brain perfusion using female Sprague-Dawley rats showed no difference in paracellular permeability to [14C]sucrose for any inflammatory agent. Western blot analyses were performed on isolated rat brain microvessels to assess the structural integrity of blood-brain barrier tight junctions. Results indicate that expression of zonula occludens-1, occludin, claudin-1, and actin remain unchanged following intravenous exposure to inflammatory agents. This study confirms that changes seen at the blood-brain barrier following a peripheral inflammation are due to physiological responses to the given inflammatory agent and not to any direct interaction between the inflammatory agent and the brain microvasculature.

KW - Blood-brain barrier

KW - Inflammation

KW - Occludin

KW - Pain

KW - Tight junctions

KW - Zonula occludens-1

UR - http://www.scopus.com/inward/record.url?scp=0037199690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037199690&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(02)02150-7

DO - 10.1016/S0014-2999(02)02150-7

M3 - Article

C2 - 12208323

AN - SCOPUS:0037199690

VL - 450

SP - 297

EP - 304

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -